Skip to content

Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study

Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06903390
Enrollment
96
Registered
2025-03-30
Start date
2024-03-01
Completion date
2025-03-01
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Health Communication, Neoplasms (Cancer / Tumors), Patient-Centered Care, Patient Empowerment, Patient Participation

Brief summary

Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients. The main questions this study aims to answer are: What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels. Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care. A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety. This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care. This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.

Interventions

BEHAVIORALQPL-based Communication Intervention

This QPL-based communication intervention stands out with the following key features: Patient-Centered & Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety. Structured Training & Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits. Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation. RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care. Focus on Empowerment & Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS). These features differentiate this intervention by offering a structured, culturally relevant approach.

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

This study follows an open-label design, meaning that participants, care providers, and investigators are aware of the assigned intervention. Masking Description: Since this study involves a communication-based intervention, blinding is not feasible, as both participants and care providers are directly involved in delivering and receiving the intervention.

Intervention model description

This study is a parallel-group randomized controlled trial designed to assess the impact of QPL-based communication intervention on patient empowerment and anxiety levels in cancer patients. Participants are assigned to either the intervention group (QPL-based communication) or the control group (standard physician-patient communication).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be over 18 years old. * Must understand and speak Turkish. * Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders). * For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.

Exclusion criteria

* Patients without regular outpatient follow-up visits. * Patients with severe cognitive or physiological deterioration affecting participation. * Patients who do not comply with the study process and requirements. * Patients who voluntarily request to withdraw from the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Patient Empowerment ScoreImmediately before the first consultation and within 1 day after the second and third consultationsAssessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.
Change in Anxiety Level (HADS)Immediately before the first consultation and within 1 day after the second and third consultationsMeasured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026